Effect of the vehicle on the topical itraconazole efficacy for treating corneal ulcers caused by Aspergillus fumigatus

Clinical and Experimental Ophthalmology

Volumn 36, Issue 4, 2008, Pages 335-338

  Martínez ramos, Marimar ^a   Claros b, José A ^a   Vale oviedo, Maria Alejandra ^a   Siso villarroel, Edgar ^a   Padilla, Rubén ^a   Santiago, Axel ^a   Simón, J Abraham ^a,b  

^a DEPARTAMENTO DE FÍSICA APLICADA   (Mexico)

^b HOSPITAL UNIVERSITARIO DE CARACAS   (Venezuela)

Author keywords

Aspergillus fumigatus; Mycotic keratitis; Topical itraconazole

Indexed keywords

ARTIFICIAL TEAR; BORIC ACID; CALCIUM CHLORIDE; CASTOR OIL; GUAR GUM; ITRACONAZOLE; MACROGOL 400; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; PROPYLENE GLYCOL; RICINOLEIC ACID; SODIUM CHLORIDE; SYSTANE; WATER; ZINC CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; AQUEOUS SOLUTION; ARTICLE; ASPERGILLUS FUMIGATUS; CONTROLLED STUDY; CORNEA ULCER; DRUG DOSAGE FORM COMPARISON; DRUG EFFICACY; DRUG RESPONSE; DRUG SOLUBILITY; FUNGAL STRAIN; KERATOMYCOSIS; NONHUMAN; RABBIT;

EID: 47649113306     PISSN: 14426404     EISSN: 14429071     Source Type: Journal    
DOI: 10.1111/j.1442-9071.2008.01767.x     Document Type: Article

References (12)

1. Upadhyay MP, Karmacharya PC, Koirala S etal. Epidemiologic characteristics, predisposing factors, and etiologic diagnosis of corneal ulceration in Nepal. Am J Ophthalmol 1991; 111: 92-9.
2. Harris DJ Jr, Stulting RD, Waring GO 3rd, Wilson LA. Late bacterial and fungal keratitis after corneal transplantation. Spectrum of pathogens, graft survival, and visual prognosis. Ophthalmology 1988; 95: 1450-7.
3. Lau D, Fedinands M, Leung L etal. Penetration of voriconazole, 1%, eye drops into human aqueous humor: A prospective open-label study. Arch Ophthalmol 2008; 126: 343-6.
4. Rao SK, Madhavan HN, Rao G, Padmanabhan P. Fluconazole in filamentous fungal keratitis. Cornea 1997; 16: 700.
5. Prajna NV, John RK, Nirmalan PK, Lalitha P, Srinivasan M. A randomized clinical trial comparing 2% econazole and 5% natamycin for the treatment of fungal keratitis. Br J Ophthalmol 2003; 87: 1235-7.
6. Martchelle L, Uy R, Perlas R, Yruma E. Topical itraconazole in the treatment of experimental aspergillus keratitis. Philipp J Ophthalmol 2001; 26: 25-31.
7. De Beule K, Van Gestel J. Pharmacology of itraconazole. Drugs 2001; 61: S27-37.
8. Kalavathy CM, Parmar P, Kaliamurthy J etal. Comparison of topical itraconazole 1% with topical natamycin 5% for the treatment of filamentous fungal keratitis. Cornea 2005; 24: 449-52.
9. Guzek JP, Roosenberg JM, Gano DL, Wessels IF. The effect of vehicle on corneal penetration of triturated ketoconazole and itraconazole. Ophthalmic Surg Lasers 1998; 29: 926-9.
10. Savani DV, Perfect JR, Cobo LM, Durack DT. Penetration of new azole compounds into the eye and efficacy in experimental Candida endophthalmitis. Antimicrob Agents Chemother 1987; 31: 6-10.
11. Rajasekaran J, Thomas PA, Kalavathy CM, Joseph PC, Abraham DJ. Itraconazole therapy for fungal keratitis. Indian J Ophthalmol 1987; 35: 157-60.
12. Agarwal PK, Roy P, Das A, Banerjee A, Maity PK, Banerjee AR. Efficacy of topical and systemic itraconazole as a broad-spectrum antifungal agent in mycotic corneal ulcer. A preliminary study. Indian J Ophthalmol 2001; 49: 173-6.